Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Uber wants to test the limits of its self-driving fleet.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Apple’s eye-tracking neural networks may be a part of its highly-anticipated AR/VR headset.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
No one should be surprised that the convicted CEO of Theranos is trying to rehab her image. What is stunning is how quickly someone took the bait.
Canada’s Liberal Party won a majority promising to distance the country from the US, a major importer of Canadian crude.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.